Abstract
Cardiac size can be regulated by the balance in activity between cardiac growth factors and inhibiting factors, chalones. This study was undertaken to verify the role of the cardiac growth factor and its purification from hypertrophied hearts. For this propose the hypertrophied hearts of renovascular hypertensive rats were used. The purification was made by using an isoelectric focusing chromatography and the HPLC method. We examined the cardiac growth effect of the isolated fractions with cultured chicken embryonic cardiac myocytes. Simultaneously, the influence of these fractions on the cardiac cell cycle was examined by DNA analysis with the flow cytometric method. If the hearts were overloaded due to hypertension, the growth of the cardiac size could be induced by increased the level of five proteins with different molecular weight and with an isoelectric point of 8.3. The significant growth activities were observed at these five proteins compared to the absence of the fractions. For the appearance of these growth effect, it is necessary that the structure of the protein is there fundamentally as a form with a molecular weight of 27 k dalton. After addition of these isolated fractions, BrdU content is S and G2 phases by flow cytometry was increased. This change indicates that the cardiac myocytes are stimulated in form DNA synthesis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Nagano M, Ohkubo T, Suzuki H: Growth factor and its role for cardiac hypertrophy. In: Jacob, Seipel, Zucher (eds.) Cardiac Dilatation. Gustav Fischer Verl, Stuttgart, New York, 1990, pp 81–88
Suzuki H, Nagai M, Ohkubo T, Nagano M: Cardiac growth factor in the hypertrophied rat heart. Jikeikai Med J 37 (Suppl): 97–106, 1990
Suzuki H, Ohkubo T, Nagano M: Cardiac growth factor. Jikei Med J (Japanese) 103: 1441–1448, 1988
Baker KM, Aceto JF: Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol 259: H610-H618, 1990
Dolbeara F, Gratzner N, Pallaricini MG, Gray WJ: Flow cytometric measurement of total DNA content and incorporated bromodesoxyuridine. Proc Natl Acad Sci 80: 5573–5577, 1983
Bugaisky L, Zak R: Biological mechanisms of hypertrophy. In: Fozzard, Haber, Jennings, Katz, Morgan (eds.) The Heart and Cardiovascular System-Scientific Foundations. Raven Press, New York, 1986, pp 1491–1506
Tsuhima T: Insulin-like growth factor. In: Ohno, Umeda, Kaji, Kasuya, Toshima (eds.) Cellular and Molecular Biology. Part II. Asakua-shoten, Tokyo, 1987, pp 25–30
Clemmons DR, van Wyk JJ: Somatomedin, Physiological control and effect on cell proliferation. In: Basegra (ed.) Tissue Growth Factors. Springer Verl. Berlin, Heidelberg, New York, 1981, pp 161–198
Morkin E, Flink IL, Goldman S: Biochemical and physiological effects of thyroid hormone on the cardiac performance. Proc Cardiovas 25: 435–464, 1983
Simpson P: Stimulation of hypertrophy of cultured neonatal rat heart cells through an a1 adrenergic receptor and induction of beating throug an a1 and β1 adrenergic receptor interaction: Evidence for independent regulation of growth and beating. Circ Res 56: 884–894, 1985
Ross R: The platelet-derived growth factor. In: Basegra (ed.) Tissue Growth Factors, Springer Verl, Berlin, Heidelberg, New York, 1989, pp 133–157
Sen S, Kundu G, Mekhail N, Castel J, Misono K, Healy B: Myotrophin: Purification of a novel peptide from spontaneously hypertensive rat heart that influences myocardial growth. J Biol Chem 265: 16635–16643, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nagano, M., Ohkubo, T., Arino, T. et al. Growth factor for cardiac hypertrophy. Mol Cell Biochem 119, 17–22 (1993). https://doi.org/10.1007/BF00926848
Issue Date:
DOI: https://doi.org/10.1007/BF00926848